Search
+
    SEARCHED FOR:

    IPO INVESTMENTS

    Ganesh Green Bharat shares list at 90% premium over IPO price

    Ganesh Green Bharat Share Price: Ganesh Green Bharat's shares debuted on the NSE SME platform with a 90% premium on Friday, opening at Rs 361 against an issue price of Rs 190. Prior to listing, the company's shares traded at a premium of Rs 170. The IPO, consisting entirely of fresh equity of 65.91 lakh shares, saw exceptional investor interest, oversubscribing 200 times by closing.

    India Inc raises record $30 billion in 6 months, riding FPO wave

    Indian companies have raised a record $29.5 billion in the equity market through IPOs & FPOs in the first half of 2024, more than double the amount raised last year. Follow-on public offers accounted for 85% of the total proceeds. Analysts anticipate a potential record year for equity issuances.

    Reliance Jio IPO: Listing likely in 2025 at $112 billion valuation, says Jefferies

    Investors anticipate the impending Reliance Jio IPO as billionaire Mukesh Ambani remains tight-lipped. The recent telecom tariff hike is seen as a precursor to this long-awaited event. Jefferies, a global investment banking firm, suggests that the high-profile listing could materialize in 2025, valuing Jio at $112 billion.

    In equity's Indian summer, IPOs and investors make hay in 2024

    The IPO market in 2024 has seen strong investor interest with 38 companies listing at an average gain of 25%. While some stocks like Jyoti CNC Automation and Exicom Tele-Systems have surged 100-300%, others are trading below offer price. Major IPOs from Bharti Hexacom and Aadhar Housing Finance have performed well.

    Ganesh Green Bharat IPO allotment: Check status, GMP, listing date and other details

    In the unlisted market, the company's shares are trading with a premium of Rs 240. If the trends sustain, the company's shares are expected to list with maximum gains of 90% on July 12. The company has priced the IPO at Rs 190 at the upper end.

    These 2 soon-to-list SME IPOs are boasting a GMP of over 100% despite NSE price cap

    Ganesh Green Bharat is enjoying a GMP approximately 120% higher than its issue price, while Effwa Infra is seeing a premium of nearly 146% above its IPO price in the unlisted market.

    • What would Hyundai IPO valuation be if priced at par with Maruti Suzuki?

      The upcoming Hyundai Motor India IPO could be priced at different levels, ranging from Rs 1,265 to Rs 1,988 per share. With plans to raise $3.5 billion, the company aims to capitalize on the low-penetrated Indian car market. Valuation concerns compared to global peers have been highlighted by experts.

      Indian IPOs keep drawing individuals on allure of quick returns

      Indian retail investors drive IPOs with 57% average gains, outperforming Asia Pacific and global averages. Data shows $10.6 billion in bids across 36 IPOs, all quotas filled. Regulatory surveillance increased. 15 companies aim to raise $11 billion. Exicom Tele-Systems saw high demand. Quick money entices investors despite minimal company analysis.

      Shein pledges to invest in UK and Europe ahead of potential IPO

      Fast fashion retailer Shein said it would invest 250 million euros ($271 million) over five years in the UK and Europe as the company battles criticism of its model based around flying cheap clothes and accessories from factories in China direct to shoppers worldwide.

      Hyundai under pressure from Tata, Mahindra as $3.5 billion India IPO looms

      Tata Motors and Mahindra challenge Hyundai for India's No.2 spot amid Hyundai's $3.5 billion IPO plan. Hyundai held 13.5% sales, Tata 13.2%, Mahindra 12.4%, Maruti Suzuki tops with 40%. Hyundai faces market challenges, acknowledges COO Tarun Garg. Significant investments in EVs and capacity expansions are planned by 2026, according to the Federation of Automobile Dealers.

      Accel and Flipkart-backed BlackBuck files DRHP with Sebi for IPO

      Bengaluru-based Zinka Logistics Solutions, India’s leading platform for truck operators, has filed its draft red herring prospectus with market regulator Sebi to launch an IPO. The IPO comprises a fresh issuance of Rs 550 crore and an OFS of up to 2.16 crore equity shares by promoters and investor selling shareholders.

      Dealmaker DAM Capital Advisors plans public issue

      DAM Capital, led by Dharmesh Mehta, targets an IPO within six months, highlighting Mumbai's investment-banking growth. Managed by Nuvama Investment Banking, the IPO includes fresh capital and an offer for sale. DAM Capital, with significant public issues, QIPs, and secondary-market block deals, plans wealth management, PMS, AIF, retail broking to rival ICICI Securities and Motilal Oswal.

      BSE SME IPO index crosses 1 lakh mark after over 5,000% rally in just 5 years

      BSE SME IPO: While the Sensex eyes 100,000 in 1-2 years, the BSE SME IPO index has already hit this milestone. Small companies entering public markets, driven by investor demand, led to this achievement. The SME IPO market surged over 5000% in 5 years and doubled this year alone.

      Emcure Pharmaceuticals IPO share allotment likely on Monday. Here's how you can check the status.
      IPO Calendar: 1 IPO, 5 listings investors need to watch out for next week

      Analysts believe that despite a temporary lull, India's strong economic fundamentals and promising growth outlook create an ideal environment for its burgeoning IPO market. They foresee significant investment in public markets and robust demand for both new-age and traditional companies in the coming months.

      At $4.2 billion, Q2 2024 IPO size records its highest growth in 2 years

      QIPs saw a rise in both value and volume compared to the previous quarter, with 20 issues raising $2.3 billion. This marks the second-highest volume since Q4 2017. The retail and consumer sector led deal activity, with an 18% increase in value over Q1 2024, despite a 7% decrease in volume.

      Emcure Pharmaceuticals IPO booked nearly 68 times so far on Day 3. Check GMP and other details

      Emcure Pharmaceuticals IPO sees strong demand with oversubscription. Anchor investors include top names. Company engaged in global pharmaceutical products. Revenue growth and plans for debt payment outlined. Book-running lead managers identified.

      HDFC Bank invests in anchor round of this high-demand SME IPO with over 100% GMP

      HDFC Bank has been allocated approximately 1.58 lakh shares worth Rs 3 crore at Rs 190 each in the anchor round of the Ganesh Green Bharath IPO, which opened for subscription recently. Other notable investors in the anchor round include Copthall Mauritius Investment, India Equity Fund, and Craft Emerging Market Fund.

      Does NSE's price capping on SME IPOs mean no multibagger returns on Day 1?

      As SME IPOs gain traction among investors, regulators are moving to formalise the market with stricter controls. The NSE recently imposed a cap on SME issue listing prices at 90%, independent of grey market trends. This impacted Nephro Care, which despite a 300% pre-listing GMP, debuted at only a 90% premium due to the exchange's price cap.

      Flood of IPOs brings sackful of bonuses to I-Bankers’ accounts

      Indian investment bankers receive generous bonuses despite a soft M&A market. Top performers at local I-banks like Kotak and Axis Capital see bonuses increase by 150-200%. Average bonuses rise by 10-25% as companies focus on talent retention. IPO activity drives record equity indices and compensation levels for MDs range from ₹3-9 crore.

      Emcure Pharmaceuticals IPO fully subscribed on Day 1. Check GMP and other details

      Emcure Pharmaceuticals' IPO attracts high demand from investors, with a price range of Rs 960-1008 per share. Analysts foresee business improvements and revenue growth potential in the global pharmaceutical market, supporting the company's expansion strategies.

      Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other details

      Emcure Pharmaceuticals' IPO has been oversubscribed nearly three times as of Thursday, the second day of bidding. The bidding concludes on July 5. The categories reserved for NII and retail investors were subscribed the most at 13 times and 3.43 times, respectively.

      Ganesh Green Bharat IPO opens today: Check issue size, price band, GMP and other details

      Ganesh Green Bharat IPO will open for subscription, aiming to raise Rs 125 crore for solar and electrical projects. The company's diversified business model and strong financial performance make it a potential investment opportunity.

      NSE imposes price control cap of 90% on SME IPOs amid froth concerns

      "To standardize the opening price discovery/ equilibrium price across exchanges during special pre-open session for initial public offer (IPO) for the SME platform, it has been decided to put an overall capping up to 90% over the Issue price for SME IPOs," NSE said in a circular.

      Renewable energy firm ACME Solar Holdings files papers for Rs 3,000-crore IPO

      The Gurugram-based company's proposed IPO is a combination of fresh issue of shares worth Rs 2,000 crore and an offer for sale (OFS) of shares valued Rs 1,000 crore by ACME Cleantech Solutions, according to the DRHP. The offer also includes a reservation for a subscription by eligible employees. The company may consider issue of securities to the tune of up to Rs 400 crore as a "pre-IPO placement". If such placement is completed, the fresh issue size will be reduced.

      Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of subscription

      Emcure Pharmaceuticals' IPO opens for subscription on July 3rd with shares trading at a Rs 265 premium in the unlisted market. The IPO includes fresh equity shares worth Rs 800 crore and an Offer For Sale (OFS) of 1.14 crore shares. Priced at Rs 960-1,008 per share, investors can bid for 14 shares per lot. The company targets to raise Rs 1,952 crore at the upper price range.

      Health insurer Niva Bupa files for Rs 3,000 crore IPO

      The company, majority owned by British United Provident Fund (Bupa), said it will issue fresh shares worth up to eight billion rupees as part of the offering.It aims to use the proceeds from that sale to strengthen its balance sheet and for operating expenses.

      Fresh capital raised via IPOs surges to a 9-year high, hints at private capex revival

      Of the ₹33,610 crore raised by 37 companies so far in 2024, about 45%, or ₹15,190 crore, were through new shares, the highest proportion since 2015, when India Inc. raised nearly 48% fresh capital, according to data from primedatabase.com. The funds raised as fresh issues in 2024 were to either finance capital assets or retire existing debt obtained to build capacities, according to IPO documents.

      Hyundai India IPO banks set for country's 2nd biggest payday with $40 million fee: Report

      The evolving financial landscape in India, characterized by the Hyundai India IPO and the rise in private company IPOs, presents significant opportunities for financial institutions like Nomura and Jefferies Financial Group to capitalize on the flourishing market and drive investment banking fees to new heights.

      Load More
    The Economic Times
    BACK TO TOP